SURVIVALDESCRIPTIVE statisticsTo the Editor, Follicular lymphoma (FL) is the most common low grade lymphoma. Stage I FL is uncommon [1]. Current treatment options for stage I FL include observation, radiotherapy (RT) and combin...doi:https://doi.org/10.3109/0284186X.2014.974829Binay Kumar ...
We assessed stage-specific trends in primary therapy and relative survival among adult follicular lymphoma (FL) patients diagnosed in the Netherlands between 1989–2016 (N = 12,372; median age, 62 years; and 21% stage I disease). Patients were stratified by disease stage and subsequently ...
Many randomized clinical trials have demonstrated the significant survival benefit of targeted therapies among patients harboring driver variants among the druggable oncogenes, such as epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK).7-9 Moreover, immune-based therapies, in ...
Despite remaining an incurable disease, overall survival improvements have been noted in patients with advanced-stage follicular lymphoma. The Follicular L... JW Friedberg - 《Seminars in Hematology》 被引量: 63发表: 2008年 Implications of the tumor microenvironment on survival and disease response in...
The model includes 1-, 3-, and 5 year predictions and is depicted in Fig. 3. The total score was calculated by adding up the scores of each predictor variable, and the corresponding survival rate can be estimated by finding the intersection of the total score with the vertical line of ...
RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-522 trial evaluating KEYTRUDA, Merck’s anti-PD-1 therapy, met its overall ...
Kedar A, Braylan RC. Lymphohistiocytic anaplastic large cell lymphoma stage I:long-term survival after resection alone[J]. Pediatr Hematol Oncol, 2000,17(3) : 261 - 268.Kedar, A. & Braylan, R.C. ( 2000 ) Lymphohistiocytic anaplastic large cell lymphoma stage I: long-term survival ...
Background: Survival rates in patients (pts) with classic Hodgkin lymphoma (HL) aged ≥60 years (y) are lower than younger pts. The difference is due to comorbidities, impaired performance status, decreased chemotherapy tolerance, and increased treatment-related toxicity and mortality. The frontline...
The overall response rate after early FCR was 92.7%. Common adverse events were hematological toxicities and infections (61.0%/41.5% of patients, respectively). After median observation time of 55.6 (0–99.2) months, event-free survival was significantly prolonged in Hi-FCR compared with Hi-W&W ...
“Small cell lung cancer remains a difficult disease to treat, as evident by the seven percent five-year survival rate and limited advancements in treatment options,” said Dr. Marjorie Green, senior vice pr...